Categories: Uncategorized

DCGI grants permit to SII for mfg of Sputnik V

The Drugs Controller General of India (DCGI) on Friday granted the Serum Institute of India permission to manufacture Russian Covid-19 vaccine Sputnik V in India.

The Serum Institute of India (SII) has been granted approval to manufacture the vaccine for examination, test and analysis with certain conditions at its licensed facility in Hadapsar, Pune. The SII had submitted an application to the DCGI in this regard on Wednesday.

The Pune-based company has collaborated with Gamaleya Research Institute of Epidemiology and Microbiology, Moscow in Russia to develop Sputnik V in India.

SII is already producing the Oxford AstraZeneca Covid-19 vaccine under the name ‘Covishield’ and has told the government it will supply 10 crore doses of it in June. The Serum Institute is also manufacturing the Novavax vaccine, the regulatory clearance for which is awaited from the US.

Medically Speaking Team

Recent Posts

One Sleepless Night Can Weaken Your Immunity and Trigger Inflammation

Sleep is often regarded as a luxury in today’s fast-paced world, but scientific research continuously…

2 days ago

Thick Heart Syndrome: A Silent Threat to Millions in India

Heart disease remains one of the leading causes of death worldwide, and in India, cardiovascular…

2 days ago

Delhi Sees Surge in H1N1 and Influenza B Cases

Delhi is witnessing a sharp rise in flu cases, particularly Influenza B and H1N1 (commonly…

2 days ago

Woman Dies During MRI Scan Due to Medical Negligence

In early February 2025, a tragic incident occurred in Eluru, Andhra Pradesh, where a 61-year-old…

2 days ago

Holi and Eye Safety: Protect Your Vision During Festivities

Holi, the festival of colors, is one of the most vibrant and joyous celebrations in…

3 days ago

FDA Recalls Popular Skincare Products Over Cancer-Causing Chemical

In a major development, the U.S. Food and Drug Administration (FDA) has issued recalls for…

3 days ago